• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于二氧化硅的纳米系统在皮肤治疗中的应用。

Silica-based nanosystems for therapeutic applications in the skin.

机构信息

Departamento de Ciencias y Tecnología Farmacéuticas, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380494, Chile.

Institut Químic de Sarrià (IQS), University Ramon Llull, Via Augusta 390, 08017 Barcelona, Spain.

出版信息

Nanomedicine (Lond). 2019 Aug;14(16):2243-2267. doi: 10.2217/nnm-2019-0052. Epub 2019 Aug 14.

DOI:10.2217/nnm-2019-0052
PMID:31411537
Abstract

Aging, exposure to oxidants, infectious pathogens, inflammogens, ultraviolet radiation and other environmental and genetic factors can result in the development of various skin disorders. Despite immense progress being made in dermatological treatments, many skin-associated problems still remain difficult to treat and various therapies have limitations. Progress in silica-based nanomaterials research provides an opportunity to overcome these drawbacks and improve therapies and is a promising tool for inclusion in clinical practice to treat skin diseases. This review focuses on the use of various types of silica nanoparticles with therapeutic applications in various skin disorders. These nanosystems improve treatment efficacy by maintaining or enhancing the effect of several drugs and are useful tools for nanomedicine, pharmaceutical sciences and future clinical applications.

摘要

衰老是、接触氧化剂、传染病病原体、促炎剂、紫外线辐射和其他环境和遗传因素会导致各种皮肤疾病的发展。尽管在皮肤病治疗方面取得了巨大进展,但许多与皮肤相关的问题仍然难以治疗,各种疗法都存在局限性。基于二氧化硅的纳米材料研究的进展为克服这些缺点和改进治疗方法提供了机会,是一种很有前途的工具,可以纳入临床实践中治疗皮肤疾病。这篇综述重点介绍了各种类型的二氧化硅纳米粒子在各种皮肤疾病中的治疗应用。这些纳米系统通过维持或增强几种药物的效果来提高治疗效果,是纳米医学、药物科学和未来临床应用的有用工具。

相似文献

1
Silica-based nanosystems for therapeutic applications in the skin.基于二氧化硅的纳米系统在皮肤治疗中的应用。
Nanomedicine (Lond). 2019 Aug;14(16):2243-2267. doi: 10.2217/nnm-2019-0052. Epub 2019 Aug 14.
2
Shape matters when engineering mesoporous silica-based nanomedicines.当工程介孔硅基纳米药物时,形状很重要。
Biomater Sci. 2016 Apr;4(4):575-91. doi: 10.1039/c5bm00589b. Epub 2016 Jan 28.
3
Mesoporous silica nanoparticles in nanomedicine applications.介孔硅纳米粒子在纳米医学中的应用。
J Mater Sci Mater Med. 2018 May 8;29(5):65. doi: 10.1007/s10856-018-6069-x.
4
Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.基于介孔硅的复合纳米结构的药物输送/成像多功能性。
Expert Opin Drug Deliv. 2014 Jun;11(6):917-30. doi: 10.1517/17425247.2014.908181. Epub 2014 Apr 19.
5
Mesoporous Silica-Based Nanoparticles for Light-Actuated Biomedical Applications via Near-Infrared Two-Photon Absorption.基于介孔二氧化硅的纳米颗粒用于通过近红外双光子吸收实现光驱动生物医学应用
Enzymes. 2018;43:67-99. doi: 10.1016/bs.enz.2018.07.004. Epub 2018 Sep 14.
6
(Phospho)lipid-based Nanosystems for Skin Administration.用于皮肤给药的(磷酸)脂质基纳米系统。
Curr Pharm Des. 2015;21(29):4174-92. doi: 10.2174/1381612821666150901095838.
7
Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.用于纳米医学的棒状介孔硅纳米粒子:最新进展与展望。
Expert Opin Drug Deliv. 2018 Sep;15(9):881-892. doi: 10.1080/17425247.2018.1517748. Epub 2018 Sep 7.
8
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.基于纳米技术的用于有效抗癌治疗的药物和制剂的最新见解。
J Nanobiotechnology. 2016 May 26;14(1):39. doi: 10.1186/s12951-016-0193-x.
9
Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer.用于癌症联合递送和联合治疗的介孔二氧化硅基纳米载体的研究进展
Expert Opin Drug Deliv. 2017 Feb;14(2):229-243. doi: 10.1080/17425247.2016.1211637. Epub 2016 Jul 25.
10
Understanding the mechanisms of silica nanoparticles for nanomedicine.了解硅纳米颗粒在纳米医学中的作用机制。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1658. doi: 10.1002/wnan.1658. Epub 2020 Jun 29.

引用本文的文献

1
Orthosilicic Acid Promotes Diabetic Wound Healing Through the PI3 K/AKT/mTOR Signaling Pathway.原硅酸通过PI3K/AKT/mTOR信号通路促进糖尿病伤口愈合。
Biol Trace Elem Res. 2025 Jun 14. doi: 10.1007/s12011-025-04670-6.
2
Ivermectin-Loaded Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In Vitro Solubility Enhancement, and Release Performance.载伊维菌素的介孔二氧化硅和聚合物纳米胶囊:对药物负载、体外溶解度提高及释放性能的影响
Pharmaceutics. 2024 Feb 26;16(3):325. doi: 10.3390/pharmaceutics16030325.
3
Microparticles as BDMDAC (Quaternary Ammonium Compound) Carriers for Water Disinfection: A Layer-by-Layer Approach without Biocide Release.
作为用于水消毒的BDMDAC(季铵化合物)载体的微粒:一种无杀菌剂释放的逐层方法。
Nanomaterials (Basel). 2023 Dec 2;13(23):3067. doi: 10.3390/nano13233067.
4
Bioadhesive 3D-Printed Skin Drug Delivery Polymeric Films: From the Drug Loading in Mesoporous Silica to the Manufacturing Process.生物粘附性3D打印皮肤给药聚合物薄膜:从介孔二氧化硅中的药物负载到制造工艺
Pharmaceutics. 2022 Dec 21;15(1):20. doi: 10.3390/pharmaceutics15010020.
5
Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives.药物递送系统与类黄酮:黑色素瘤治疗的当前知识与未来展望
Micromachines (Basel). 2022 Oct 27;13(11):1838. doi: 10.3390/mi13111838.
6
How Effective are Nano-Based Dressings in Diabetic Wound Healing? A Comprehensive Review of Literature.纳米敷料在糖尿病创面愈合中的效果如何?文献综述。
Int J Nanomedicine. 2022 May 11;17:2097-2119. doi: 10.2147/IJN.S361282. eCollection 2022.
7
Formulation of Tioconazole and Essential Oil Pickering Emulsions for Onychomycosis Topical Treatment.酮康唑和精油的制剂用于治疗甲真菌病的局部治疗。
Molecules. 2020 Nov 26;25(23):5544. doi: 10.3390/molecules25235544.
8
Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment.介孔二氧化硅纳米颗粒作为多功能控释药物递送纳米平台用于传染病治疗的研究进展。
Pharm Res. 2020 Sep 7;37(10):191. doi: 10.1007/s11095-020-02917-6.
9
Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications.基于纳米抗氧化剂的二氧化硅颗粒作为用于药物递送应用的类黄酮载体
Pharmaceutics. 2020 Mar 26;12(4):302. doi: 10.3390/pharmaceutics12040302.